Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
CureMatch, Inc., based in San Diego, is a digital health company focused on personalized medicine and combination therapy in oncology. Combination therapy has been used effectively in the treatment of other diseases, such as HIV/AIDS, and is considered by many to be the future of cancer treatment. CureMatch’s decision support system guides oncologists in the selection of combinations of cancer drugs that are personalized for individual patients, based on the molecular profile of the patient’s own tumor. The CureMatch platform with a foundation in oncology, genetics, proteomics, biochemistry, and cell biology was originally developed and licensed by a multidisciplinary team at UC San Diego Moore’s Cancer Center and the San Diego Supercomputer Center.